Dr. Sai Lakshmi Daayana
MBBS, MD RCOG approved Sub-specialty training in Gynaecological Oncology
Consultant- Surgical Gynaecological Oncology
Gynecologic Oncologist- 21 Years of Experience
Doctor Profile
Dr. Sai Lakshmi Daayana is a Gynecologic Oncologist and associated with Apollo Health City, Jubilee Hills, Hyderabad. She completed her MBBS, MRCOG, and MD RCOG approved Sub-specialty training in Gynaecological Oncology (UK). She has been awarded prizes for ‘best poster presentations’ at British Colposcopy conferences (BSCCP), 2010, 2012 UK and ‘best oral presentation’ at the 7th RCOG International Scientific Meeting, 2008 Montreal, Canada. Earlier, Dr. Daayana has also worked as a Consultant in Surgical Gynaecological Oncology – St James Institute of Oncology, Leeds (UK) 2013 – 2016 and Clinical Lecturer in Surgical Gynaecological Oncology – Christie Hospital, Manchester (UK) 2009 – 2013.
Education
- MBBS – University of Health Sciences, 1997
- MD RCOG approved Sub-specialty training in Gynaecological Oncology – University of Manchester, UK, 2011
Memberships
- Member – Royal College of Obstetricians & Gynaecologists, 2002
- Member – European Society of Gynaecology Oncology
- Member – British Society of Gynaecology Oncology
Training
- CCT in Obstetrics & Gynaecology – Royal College of Obstetricians & Gynaecologists, UK, 2013
Experience
- Surgical Gynaecological Oncology, Consultant- Apollo Cancer Institutes, Jubilee Hills, Hyderabad , currently working
- Surgical Gynaecological Oncology , Consultant- St James Institute of Oncology, Leeds, UK , 2013
- Surgical Gynaecological Oncology, Clinical Lecturer- Christie hospital, Manchester, UK , 2009
Awards and Achievements
- Awarded ‘Runner-up Prize medal for MRCOG by the Royal College of Obstetricians and Gynaecologists
- Daayana S, Winter U, Stern PL, Kitchener HC. The Role of Photodynamic Therapy in the Management of Vulval Intraepithelial Neoplasia. Photochem Photobiol Sci.2011 May 1;10(5):802-9.
- Seroepidemiology of Human Papillomavirus 16 (HPV16)L2 and generation of L2-Specific Human Chimeric Monoclonal Antibodies. Wamg JW, Jagu S, Wu WH, Viscidi RP, Macgregor-Da A, Fogel JM, Kwak K, Daayana S, Kitchener H, Stern PL, Gravitt PE, Trimble CL, Roden RB. Clin Vaccine Immunol. 2015 Jul;22(7):806-16.
